期刊文献+

78例糖皮质激素性白内障临床分析 被引量:4

Clinical analysis on 78 cases of glucocorticoid induced cataract
下载PDF
导出
摘要 目的探讨糖皮质激素性白内障的临床特点。方法分析内江市中医院78例激素性白内障患者(155眼)使用激素的原因,晶体混浊程度与用药时间、视力的关系。结果全身用药15例、局部用药63例;用药时间小于12个月者89眼,12个月者66眼。随着用药时间的增加,晶体混浊程度Ⅰ级、Ⅱ级所占比例降低,而Ⅲ级、Ⅳ级比例增加,Ⅰ级、Ⅲ级差异具有统计学意义(P〈0.05)。视力小于0.4组中Ⅲ级比例最高;0.4-1.0组中以Ⅰ级、Ⅱ级为主;〉1.0组中Ⅰ级比例最高,视力小于0.4组与0.4-1.0组、〈0.4组与〉1.0组差异具有统计学意义(P〈0.05)。结论使用糖皮质激素时间越长,剂量越大,激素性白内障的程度越重,视力越差。使用糖皮质激素时要随时警惕激素性白内障的发生,定期检查眼部。 Objective To investigate the clinical features of glucocorticoid induced cataracts.Methods To analyse the reasons of using hormone in 78 cases of glucocorticoid induced cataract in our hospital(155 eyes).To explore the relationship between the time of medication,visual acuity and crystal turbidity.Results 15 cases were systemic administration.63 cases were local administration.The therapeutic time was shorter than 12 months in 89 cases and longer than 12 months in 66 cases.With the time increasing,the proportion of the I and II level of crystal turbidity was decreased.But the proportion of the Ⅲ and Ⅳ level of crystal turbidity was increased.The difference of the Ⅰ and Ⅲ level had statistically significance(P0.05).The proportion of the III level was the highest in the visual acuity 0.4 group.The I and II level were major in the visual acuity 0.4-1.0 group.The proportion of the I level was the highest in the visual acuity 1.0 group.The difference was statistically significant between the visual acuity 0.4 group and the visual acuity 0.4-1.0 group.The difference was statistically significant between the visual acuity 0.4 group and the visual acuity 1.0 group.Conclusion The degree of crystal turbidity could be greater and the visual acuity could be worse when the time of using the hormone is longer and the dose is greater.We must be alert of glucocorticoid induced cataract and take regularly eye-checking when using gluoocorticoid.
作者 向红
出处 《检验医学与临床》 CAS 2011年第3期297-298,共2页 Laboratory Medicine and Clinic
关键词 激素 白内障 晶体 hormone cataract crystal
  • 相关文献

参考文献6

  • 1肖骏,魏世辉.糖皮质激素在眼科的应用[J].中国实用眼科杂志,2004,22(12):960-963. 被引量:22
  • 2李凤鸣.眼科全书[M].北京:人民卫生出版社,1997.3254-3256.
  • 3Black RL,Oglesby RB,Von Sallmann L,et a1.Posterior subcapsular cataracts induced by corticosteroids in patients with rheumatoid arthritis[J].JAMA,1960,174(9):166-171.
  • 4Ernst P,Baltzan M,Deschenes J,et a1.Low-dose inhaled and nasal corticosteroid use and the risk of cataracts[J].Eur Respir J,2006,27(6):1168-1174.
  • 5王建伟,严宏.激素性白内障的发病机制研究[J].国际眼科杂志,2004,4(2):312-317. 被引量:7
  • 6刘家琦,李凤鸣.实用眼科学[M].2版.北京:人民卫生出版社,2005:259-261.

二级参考文献65

  • 1叶天才,刘东光,余敏斌,孙桂珍.糖皮质激素性白内障93例临床分析[J].中华眼科杂志,1995,31(6):443-446. 被引量:14
  • 2Pescosolido N, Miccheli A, Manetti C, Iannetti GD, Feher J, Cavallotti C.Metabolic changes in rabbit lens induced by treatment with dexamethasone.Ophthalmic Res, 2001 ;33(2):68-74
  • 3Watanabe H, Kosano H, Nishigori H. Steroid-induced short term diabetes in chick embryo: reversible effects of insulin on metabolic changes and cataract formation. Invest Ophthalmol Vis Sci, 2000;41(7):1846-1852
  • 4Veenstra DL, Best JH, Hornberger J, Sullivan SD, Hricik DE. Incidence and long-term cost of steroid-related side effects after renal transplantation.Am J Kidney Dis , 1999;33(5):829-839
  • 5Kojima M, Shui YB, Nagata HMM, Hockwin O, Sasaki K, Takahashi N.Low vitamin E level as a subliminal risk factor in a rat model of prednisolone-induced cataract. Invest Ophthalmol Vis Sci,2002;43:1116-1120
  • 6Dickerson JE, Dotzel JE, Clark AF. Steroid-induced cataract: new perspectives from in vitro and lens culture studies. Exp Eye Res ,1997;65:507-516
  • 7Muller M, Renkawitz R. The glucocorticoid receptor. Biochim Biophys Acta, 1991;1088:171-182
  • 8Ng JS, Wong W, Law RW, Hui J, Wong EN, Lam DS. Ocular complications of paediatric patients with nephrotic syndrome. Clin Expo Ophvhalmol,2001 ;29(4):239-243
  • 9Jobling AI, Augusteyn RC. Steroid adduct formation with lens crystallins.Clin Exp Optometry, 1999;82(4):130-136
  • 10Hook DWA, Harding JJ. Inactivation of glyceraldehydes 3-phosphate dehydrogenase by sugars, prednisolone 21-hemisuccinate, cyanate and other small molecules. Biochim Biophys Acta, 1997; 1362:232-242.

共引文献135

同被引文献45

  • 1王柏川,叶剑.糖皮质激素性白内障研究进展[J].眼视光学杂志,2007,9(4):281-285. 被引量:6
  • 2Prokofyeva E, Wegener A, Zrenner E. Cataract prevalence and prevention in Europe: a literature review. Acta Ophthalmologica, 2012, 91(5):395-405.
  • 3Sternberg K, Terwee T, Stachs O, et al. Drug-induced secondary cataract prevention: experimental ex vivo and in vivo results with disulfiram, methotrexate and actinomycin D. Ophthalmic Res, 2010, 44(4):225-236.
  • 4Li J, Tripathi RC, Tripathi BJ. Drug-induced ocular disorders. Drug Saf, 2008, 31 (2): 127-141.
  • 5Pascolini D, Mariotti SP. Global estimates of visual impairment: 2010 [ J ]. British Journal of Ophthalmology, 2012,96 ( 5 ) : 614 - 618.
  • 6Prokofyeva E, Wegener A,Zrenner E. Cataract prevalence and prevention in Europe:a literature review [ J ]. Acta Ophthalmologica, 2013,91 (5) :395 -405.
  • 7Richter GM, Choudhury F,Torres M, et al. Risk factors for incident cortical,nuclear, posterior subcapsular, and mixed lens opacities: the Los Angeles Latino eye study [ J ]. Ophthahnology, 2012,119 (10 ) :2040 - 2047.
  • 8Grant WM. Toxicology of the Eye[ M]. Thomas, 1962.
  • 9Van Den Brule J, Degueldre F, Galand A. Drug - induced cataracts [ J ]. Revue Medicale de Liege, 1998,53 ( 12 ) :766 - 769.
  • 10Wang C, Dawes LJ, Liu Y, et al. Dexamethasone influences FGF - induced responses in lens epithelial explants and promotes the posterior capsule coverage that is a feature of glucocorticoid - induced cataract [ J ]. Experimental Eye Research, 2013, 111 : 79 - 87.

引证文献4

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部